Moffitt Cancer Center And InSightec Host Special Grand Rounds Presentation

January 12, 2010

Tampa, FL  – Moffitt Cancer Centerand InSightecwill host a free special Grand Rounds presentation from 12 to 1 p.m. Jan. 15 in the Ted and Marty Couch Auditorium at the Vincent A. Stabile Research Building, 12902 Magnolia Drive.

 Dr. Mark David Hurwitz, vice chief of the Department of Genitourinary Radiation Oncology at the Brigham and Women’s Hospital in Boston, will present, “MR Guided Focused Ultrasound Surgery: Current Status and Future Directions.”

 Hurwitz will examine the latest information on MR guided focused ultrasound surgery and the ExAblate system by InSightec. He will lead a discussion on the following topics:

  • The advantages of InSightec’s noninvasive, ionized radiation-free magnetic resonance-guided focused ultrasound surgery (MRgFUS) over other thermal ablative cancer therapies
  • The current approved and clinical research applications of MRgFUS
  • The future role of MRgFUS in multidisciplinary cancer care

 A small model of the ExAblate table and a cutaway of the MRI will be in the reception area for viewing.

 This presentation is open to the public, and anyone with an interest in the future of cancer care is welcome to attend. No continuing medical education will be provided for this lecture.

 Light snacks and refreshments will be served in the atrium from 1 to 2 p.m. R.S.V.P. to Sheila Findley at, or call (813) 745-2286.

 About InSightecInSightec Ltd. is a privately held company owned by Elbit Imaging, General Electric, MediTech Advisors, LLC and employees. It was founded in 1999 to develop the breakthrough MR guided Focused Ultrasound technology and transform it into the next generation operating room. Headquartered near Haifa, Israel, the company has over 160 employees and has invested more than $150 million in research, development, and clinical investigations. Its U.S. headquarters are located in Dallas, Texas. For more information, please go to:


About Moffitt Cancer Center

Located in Tampa, Florida, Moffitt Cancer Center  is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.